Stay updated on Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Sign up to get notified when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.

Latest updates to the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedUpdated operating-status notice and version to v3.2.0, replacing v3.1.0; core content now includes government funding status and NIH Clinical Center operating details.SummaryDifference2%
- Check25 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.1%
- Check39 days agoChange DetectedRevision bumped from v3.0.1 to v3.0.2; the 'Back to Top' navigation element has been removed.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.1%
- Check53 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new medical topics related to various diseases, while removing specific location details and some pharmacological terms.SummaryDifference3%
- Check68 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.